Vertex Pharmaceuticals Exec Says Cystic Fibrosis Portfolio Has About 9% Exposure To Medicare And About 23% Exposure To Medicaid - Goldman Sachs Conference

Vertex Pharmaceuticals Inc VRTX.O:

• VERTEX PHARMACEUTICALS EXEC SAYS CYSTIC FIBROSIS PORTFOLIO HAS ABOUT 9% EXPOSURE TO MEDICARE AND ABOUT 23% EXPOSURE TO MEDICAID - GOLDMAN SACHS CONFERENCE

• VERTEX PHARMACEUTICALS EXEC SAYS LARGER HOSPITALS HAVE ADDED JOURNAVX TO THEIR FORMULARY AND EXPECT MORE IN H2 2025

Source text: [ID:]